Pages that link to "Q77920172"

The following pages link to Analysis of secretory group II phospholipase A2 expression in human aortic tissue in dependence on the degree of atherosclerosis (Q77920172):

Displaying 20 items.

• Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation (Q24309900) (← links)
• Transcriptional regulation of the rat type IIA phospholipase A2 gene by cAMP and interleukin-1beta in vascular smooth muscle cells: interplay of the CCAAT/enhancer binding protein (C/EBP), nuclear factor-kappaB and Ets transcription factors (Q28564877) (← links)
• Phospholipase A2 enzymes (Q28609770) (← links)
• AML1 deletion in adult mice causes splenomegaly and lymphomas. (Q33369036) (← links)
• Secretory phospholipase A2, group IIA is a novel serum amyloid A target gene: activation of smooth muscle cell expression by an interleukin-1 receptor-independent mechanism (Q33581415) (← links)
• Diversity and regulatory functions of mammalian secretory phospholipase A2s. (Q34212477) (← links)
• Role of Monocytes in Atherogenesis (Q35541858) (← links)
• LDL phospholipid hydrolysis produces modified electronegative particles with an unfolded apoB-100 protein (Q36058820) (← links)
• Alteration in the activation state of new inflammation-associated targets by phospholipase A2-activating protein (PLAA) (Q38293331) (← links)
• Interferon-gamma induces secretory group IIA phospholipase A2 in human arterial smooth muscle cells. Involvement of cell differentiation, STAT-3 activation, and modulation by other cytokines (Q38312263) (← links)
• Identification of the phospholipase A(2) isoforms that contribute to arachidonic acid release in hypoxic endothelial cells: limits of phospholipase A(2) inhibitors (Q42517280) (← links)
• Deficiency in sPLA(2) does not affect HDL levels or atherosclerosis in mice (Q44021015) (← links)
• Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes (Q44283353) (← links)
• Augmented PLA2Activity in Pre-eclamptic Decidual Tissue—A Key Player in the Pathophysiology of ‘Acute Atherosis’ in Pre-eclampsia? (Q44633217) (← links)
• Secretory phospholipase A2 in patients with coronary artery disease. (Q46008011) (← links)
• Visceral adipose tissue accumulation, secretory phospholipase A2-IIA and atherogenecity of LDL. (Q46988898) (← links)
• Diverse activity of human secretory phospholipases A2 on the migration of human vascular smooth muscle cells. (Q53496226) (← links)
• Quantitation of secretory group V phospholipase A(2) in human tissues by sandwich enzyme-linked immunosorbent assay. (Q54546493) (← links)
• Group-II phospholipase A(2) enhances oxidized low density lipoprotein-induced macrophage growth through enhancement of GM-CSF release (Q73141391) (← links)
• Differences between group X and group V secretory phospholipase A(2) in lipolytic modification of lipoproteins (Q84394589) (← links)